Key facts
- It has raised $60.1M across 1 recorded rounds; the latest was Early Stage VC ($7.1M) in Oct 2024.
- Notable investors include MedTech Innovator, Mission BioCapital, Baruch Future Ventures, Constellar Ventures, KCK Group — 14 tracked in total.
- Avvio Medical has filed 1 Form D with the SEC, most recently Nov 2024 ($7.1M sold to 25 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Avvio Medical
Funding rounds
1 roundsAbout Avvio Medical
Developer of a medical device designed to improve patient outcomes with new products and procedures. The company's device addresses the painful condition of kidney stones with a non-invasive treatment to eliminate kidney stones without anesthesia or imaging, enabling patients to treat urinary stone disease effectively with a simple outpatient procedure.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2014
- Employees
- 30
- Website
- avviomedical.com/
- Ownership
- Privately Held (backing)
Avvio Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Avvio Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Avvio Medical in its N-PORT filings yet. We sweep new filings monthly.